(30) reported that in ER-α36+ breast cancer cells, tamoxifen or estrogen could induce the nuclear translocation of ER-α36 to regulate the transcriptional activity of ER-α to increase ALDH1A1 expression. Here, ESR1 is linked to breast cancer.